| |
Newsroom /
Business
/
Business
/
The Future of the Cardiovascular Devices Market to 2012
The Future of the Cardiovascular Devices Market to 2012
The global Drug Eluting Stents (DES) market valued at $5.75 billion in 2007 is expected to grow by 7.2% during 2007-2012 to reach $8.15 billion by 2012.
Hyderabad,
AP,
India
(prbd.net)
14/10/2009
"The Future of the Cardiovascular Devices Market to 2012"
Positive clinical outcomes from Abbott Vascular’s XIENCE™ V Everolimus Eluting Coronary Stent and Medtronic’s Endeavor® Zotarolimus-Eluting Coronary Stent and the subsequent US launch that followed helped stabilize the DES market in 2008.
Very few medical equipment sectors were as dynamic as the DES market during the past few years. More than 80% growth in 2004, a decline of 17.1% in 2007, a monopolistic market for most of its first year of launch in 2003 and a fiercely competitive market now – the DES sector has seen it all. Even as the market was grappling with concerns over late stage thrombosis following the use of DES in 2005-06, the results of COURAGE trial in March, 2007 worsened the situation and stent sales slipped down to a record level. Leading players in this sector showed revenue erosion to the tune of 20-30%. The market which showed the first sign of a revival in early 2008, recorded a positive yearly growth over 2007.
Cardiac Resynchronization Therapy to Bolster Growth in the Cardiac Rhythm Management Market
The Cardiac Resynchronization Therapy (CRT) devices market valued at $3.9 billion in 2007 is forecast to grow by 17.6% annually to reach $8.76 billion by 2012, accounting for 54.7% of the Cardiac Rhythm Management (CRM) market value. The CRM market valued at $9.05 billion in 2007 is expected to grow by 12.1% annually during 2007-2012 to reach $16.02 billion by 2012.
The increase in the use of CRT will be aided by high disease incidence. For instance, more than 22 million people worldwide suffer from congestive heart failure (CHF), a potentially debilitating disease. With more than half a million new CHF cases being detected every year in the US alone, the market is slated to continue its growth trajectory.
Percutaneous Procedures to Drive Growth in the Heart Valves Market
Driven by an increase in acceptance and penetration of percutaneous procedures, the global heart valves market, valued at $1.22 billion in 2007 is expected to grow by 5.4% annually during 2007-2012 to reach $1.59 billion by 2012.
The shift from traditional implantation of valves to the new technology of transcatheter valves is one of the key events that substantiate this trend. The time saving, less painful and minimally invasive characteristics associated with this procedure will continue to bolster the penetration of transcateter valves.
Industry Consolidations Will Continue To Reshape the Cardiovascular Devices Competitive Landscape
The global cardiovascular devices market is set to see heightened consolidation activity, driven primarily by Mergers & Acquisitions (M&As) in the interventional cardiology, cardiovascular surgery, and peripheral vascular devices market segments. In 2007, a total of 134 M&A deals were signed in the cardiovascular devices market, with interventional cardiology, cardiovascular surgery, and peripheral vascular devices categories together accounting for 52% of the deal volume, according to Global Markets Direct’s medical equipment deals database. The recent devaluation in market worth of small and mid-cap companies in the cardiovascular device sector in light of the financial crisis is expected to trigger fresh bouts of consolidation in the next 3-5 year period.
For more information on this report click here:
http://www.global-market-research-data.com/Report.aspx?ID=The_Future_of_the_Cardiovascular_Devices_Market_to_2012
The global cardiovascular devices market, driven primarily by an ever expanding patient base undergoing cardiac procedures, has emerged as the largest and one of the fastest growing markets in the medical equipment industry. Global Markets Direct’s “The Future of the cardiovascular devices market to 2012” report provides key data, information and analysis on the global cardiovascular devices market. The report provides market landscape, competitive landscape and market trends information on 7 market categories including cardiac rhythm management, interventional cardiology, cardiovascular prosthetic devices, cardiovascular surgery, peripheral vascular devices, electrophysiology, and cardiovascular monitoring and diagnostic devices. This report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.
For more information on this report click here:
http://www.global-market-research-data.com/Report.aspx?ID=The_Future_of_the_Cardiovascular_Devices_Market_to_2012
Or visit GlobalData’s Report Store:
http://www.globaldata.com/reportstore
About
GlobalData is a global market intelligence services company providing information research and analysis products and services.
|